Global licensing PharmaCielo holds the world’s largest licensed cannabis production footprint with Colombian licenses for unrestricted THC and CBD percentages, enabling scalable cross-border B2B supply of medicinal cannabis extracts to large distributors, finished goods manufacturers, research bodies, and pharmaceutical companies.

Strategic hubs Headquartered in Canada with Colombian operations and expansive cultivation capacity, the dual-country structure supports regulatory confidence, stable supply, and potential preferential access for clients seeking compliant, traceable medicinal cannabis oils and extracts.

Cannabis extracts focus The company targets standardized medicinal-grade cannabis oil extracts and related products, presenting opportunities to partner with pharmaceutical developers, natural product formulators, and contract manufacturers seeking consistent, quality raw materials and finished extract solutions.

Financial momentum Recent reports indicate positive cash-flow and EBITDA signals alongside insider funding activity, suggesting improving financial health and potential for scalable volume deals, strategic collaborations, and growth-oriented credit or milestone-based arrangements.

Sustainability edge Mass cultivation capacity in Colombia combined with climate and compliance advantages positions PharmaCielo as a reliable source of GMP-grade cannabis inputs, appealing to buyers prioritizing ethical sourcing, regulatory alignment, and long-term supply security.